Detalhe da pesquisa
1.
Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia.
Genes Dev;
33(17-18): 1265-1279, 2019 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31395741
2.
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.
Blood;
116(7): 1105-13, 2010 Aug 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20448109
3.
Inter- and intra-observational variability in immunohistochemistry: a multicentre analysis of diffuse large B-cell lymphoma staining.
Histopathology;
61(1): 18-25, 2012 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22372580
4.
Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides.
Exp Dermatol;
21(8): 632-4, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22776000
5.
BET inhibition disrupts transcription but retains enhancer-promoter contact.
Nat Commun;
12(1): 223, 2021 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33431820
6.
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation.
Cell Rep;
35(6): 109101, 2021 05 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33979616
7.
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
Haematologica;
95(3): 432-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20207847
8.
Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
J Cell Mol Med;
13(7): 1248-60, 2009 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19413891
9.
The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia.
Nat Commun;
9(1): 1622, 2018 04 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29692408
10.
Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.
Haematologica;
92(8): 1059-66, 2007 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17640856
11.
MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
Exp Hematol;
47: 64-75, 2017 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27856324
12.
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.
Cell Rep;
18(2): 482-495, 2017 01 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28076791
13.
Differential expression of EDF-1 and endothelial nitric oxide synthase by proliferating, quiescent and senescent microvascular endothelial cells.
Biochim Biophys Acta;
1745(2): 265-72, 2005 Sep 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16055206
14.
Endothelial stress by gravitational unloading: effects on cell growth and cytoskeletal organization.
Biochim Biophys Acta;
1642(3): 173-9, 2003 Oct 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14572900
15.
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199.
Cell Rep;
13(12): 2715-27, 2015 Dec 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26711339
16.
Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.
Cancer Cell;
27(3): 409-25, 2015 Mar 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25759025
17.
Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy.
Br J Haematol;
145(4): 545-8, 2009 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19298586
18.
MicroRNA expression in chronic lymphocytic leukaemia.
Br J Haematol;
147(3): 398-402, 2009 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19681887
19.
Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteins.
Mol Cell Oncol;
1(2): e955330, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27308325
20.
RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
Cell Rep;
3(1): 116-27, 2013 Jan 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23352661